Caspase-8 gene expression in neuroblastoma

Annals of the New York Academy of Sciences

Volumn 1028, Issue , 2004, Pages 157-167

  Casciano, Ida ^a   Banelli, Barbara ^a   Croce, Michela ^a   De Ambrosis, Alessandro ^a   Di Vinci, Angela ^a   Gelvi, Ilaria ^a   Pagnan, Gabriella ^b   Brignole, Chiara ^b   Allemanni, Giorgio ^a   Ferrini, Silvano ^a   Ponzoni, Mirco ^b   Romani, Massimo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Apoptosis; Caspase 8 gene (CASP8); Expression; Methylation; Neuroblastoma (NB); Regulation; Tumor

Indexed keywords

AZACITIDINE; CASPASE 8; FENRETINIDE; GAMMA INTERFERON;

CONFERENCE PAPER; DNA METHYLATION; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; PROGNOSIS; PROTEIN EXPRESSION;

EID: 20144367828     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1322.017     Document Type: Conference Paper

References (25)

1. BRODEUR, G.M. 2003. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 3: 203-216.
2. MILLER, R.W., J.L. YOUNG & B. NOVAKOVI. 1995. Childhood cancer. Cancer 75: 395-405.
3. LADENSTEIN, R., T. PHILIP, C. LASSET et al. 1998. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry. J. Clin. Oncol. 16: 953-965.
4. MARIS, J.M. & K.K. MATTHAY. 1999. Molecular biology of neuroblastoma. J. Clin. Oncol. 17: 2264-2279.
5. OUE, T., M. FUKUZAWA, T. KUSAFUKA et al. 1996. In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: relation to apoptosis and spontaneous regression. J. Pediatr. Surg. 31: 251-257.
6. ISLAM, A., H. KAGEYAMA, N. TAKADA et al. 2000. High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19: 617-623.
7. CASCIANO, I., K. MAZZOCCO, L. BONI et al. 2002. Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ. 9: 246-251.
8. BOLDIN, M.P., T. GONCHAROV, Y.V. GOLTSEV & D. WALLACH. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85: 803-815.
9. SCAFFIDI, C., J.P. MEDEMA, P.H. KRAMMER & M. PETERS. 1997. FLICE is predominantly expressed as two functionally active isoforms, caspase 8/a and caspase 8/b. J. Biol. Chem. 272: 26953-26958.
10. BAYLIN, S.B. & J.G. HERMAN. 2000. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16: 168-174.
11. TAKITA, J., H.W. YANG, Y.Y. CHEN et al. 2001. Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Oncogene 20: 4424-4432.
12. TEITZ, T., T. WEI, M.B. VALENTINE et al. 2000. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat. Med. 6: 529-535.
13. EGGERT, A., M.A. GROTZER, T.J. ZUZAK et al. 2001. Resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res. 61: 1314-1319.
14. POULAKI, V., N. MITSIADES, M. ROMERO & M. TSOKOS. 2001. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2. Cancer Res. 61: 4864-4872.
15. BANELLI, B., I. CASCIANO, M. CROCE et al. 2002. Expression and methylation of CASP8 in neuroblastoma: identification of a promoter region. Nat. Med. 8: 1333-1335.
16. PONZONI, M., P. BOCCA, V. CHIESA et al. 1995. Differential effects of N-(4-hydroxyphenyl) retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res. 55: 853-861.
17. CASCIANO, I., A. DE AMBROSIS, M. CROCE et al. 2004. Expression of the caspase-8 gene in neuroblastoma cells is regulated through an essential interferon-sensitive response element. Cell Death Differ. 11: 131-134.
18. FULDA, S. & K.M. DEBATIN. 2002. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene 21: 2295-2308.
19. HERMAN, J.G., J.R. GRAFF, S. MYOHANEN et al. 1996. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93: 9821-9826.
20. SADRI, R. & P.J. HORNSBY. 1996. Rapid analysis of DNA methylation using new restriction enzyme sites created by bisulfite modification. Nucleic Acids Res. 24: 5058-5059.
21. XIONG, Z. & P. LAIRD. 1997. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25: 2532-2534.
22. FROMMER, M., L.E. MCDONALD, D.S. MILLAR et al. 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89: 1827-1831.
23. FULDA, S., M.U. KUFER, E. MEYER et al. 2001. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 20: 5865-5877.
24. SANTORO, R. & I. GRUMMT. 2001. Molecular mechanisms modeling methylation-dependent silencing of ribosomal gene transcription. Mol. Cell 8: 719-725.
25. POGRIBNY, I.P., M. POGRIBNA, J.K. CHRISTMAN & S.J. JAMES. 2000. Single-site methylation within the p53 promoter region reduces gene expression in a reporter gene construct: possible in vivo relevance during tumorigenesis. Cancer Res. 60: 588-594.